These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36766845)

  • 41. Optically Manipulated Microtools to Measure Adhesion of the Nanoparticle-Targeting Ligand Glutathione to Brain Endothelial Cells.
    Fekete T; Mészáros M; Szegletes Z; Vizsnyiczai G; Zimányi L; Deli MA; Veszelka S; Kelemen L
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39018-39029. PubMed ID: 34397215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood-brain barrier (BBB) toxicity and permeability assessment after L-(4-¹⁰Boronophenyl)alanine, a conventional B-containing drug for boron neutron capture therapy, using an in vitro BBB model.
    Roda E; Nion S; Bernocchi G; Coccini T
    Brain Res; 2014 Oct; 1583():34-44. PubMed ID: 25128598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gold Nanoparticles Increase Endothelial Paracellular Permeability by Altering Components of Endothelial Tight Junctions, and Increase Blood-Brain Barrier Permeability in Mice.
    Li CH; Shyu MK; Jhan C; Cheng YW; Tsai CH; Liu CW; Lee CC; Chen RM; Kang JJ
    Toxicol Sci; 2015 Nov; 148(1):192-203. PubMed ID: 26272951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Copper transport mediated by nanocarrier systems in a blood-brain barrier in vitro model.
    Fehse S; Nowag S; Quadir M; Kim KS; Haag R; Multhaup G
    Biomacromolecules; 2014 May; 15(5):1910-9. PubMed ID: 24725062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
    Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
    Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier.
    Hsu J; Rappaport J; Muro S
    Pharm Res; 2014 Jul; 31(7):1855-66. PubMed ID: 24558007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uptake of polymeric nanoparticles in a human induced pluripotent stem cell-based blood-brain barrier model: Impact of size, material, and protein corona.
    Onyema HN; Berger M; Musyanovych A; Bantz C; Maskos M; Freese C
    Biointerphases; 2021 Mar; 16(2):021004. PubMed ID: 33765771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A combination of receptor mediated transcytosis and photothermal effect promotes BBB permeability and the treatment of meningitis using itraconazole.
    Zhang SS; Asghar S; Ye JX; Lin L; Ping QN; Chen ZP; Shao F; Xiao YY
    Nanoscale; 2020 Dec; 12(46):23709-23720. PubMed ID: 33231242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy.
    Martins C; Araújo F; Gomes MJ; Fernandes C; Nunes R; Li W; Santos HA; Borges F; Sarmento B
    Eur J Pharm Biopharm; 2019 May; 138():111-124. PubMed ID: 29397261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
    Zhou X; Smith QR; Liu X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Passage of Magnetic Tat-Conjugated Fe
    Zhao X; Shang T; Zhang X; Ye T; Wang D; Rei L
    Nanoscale Res Lett; 2016 Dec; 11(1):451. PubMed ID: 27726119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
    Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A bacteria deriving peptide modified dendrigraft poly-l-lysines (DGL) self-assembling nanoplatform for targeted gene delivery.
    Liu Y; He X; Kuang Y; An S; Wang C; Guo Y; Ma H; Lou J; Jiang C
    Mol Pharm; 2014 Oct; 11(10):3330-41. PubMed ID: 24964270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer.
    Gonzales-Aloy E; Ahmed-Cox A; Tsoli M; Ziegler DS; Kavallaris M
    Adv Drug Deliv Rev; 2023 May; 196():114777. PubMed ID: 36931346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC/D3 cell line.
    Guccione C; Oufir M; Piazzini V; Eigenmann DE; Jähne EA; Zabela V; Faleschini MT; Bergonzi MC; Smiesko M; Hamburger M; Bilia AR
    Eur J Pharm Biopharm; 2017 Oct; 119():253-263. PubMed ID: 28652141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.
    Liu Y; Huang R; Han L; Ke W; Shao K; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Sep; 30(25):4195-202. PubMed ID: 19467700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.